87860:RICKETTSIA ANTIBODY GROUP
Author PeaceHealth Laboratories
Modified by
 Print View Attached Docs: |
| Alias Names: |
Typhus, RMSF, Rocky Mountain spotted fever |
| Methodology: |
Indirect Fluorescent Antibody (IFA) |
| Edit Date: |
4/2/2005 |
| Performed: |
Monday-Friday |
| Released: |
7-10 days after setup at PeaceHealth Laboratories’ reference lab. |
| CPT Code: |
86757-90 |
| Specimen Collection Details |
| Collection: |
One 7.5 mL serum separator tube (SST). |
| Handling: |
Allow to clot, centrifuge and separate serum from cells and pour into a plastic vial. Indicate date of onset and symptoms. |
| Standard Volume: |
2 mL serum. |
| Minimum Volume: |
1 mL serum. |
| Transport: |
Refrigerated. |
| Comments: |
For Oregon clients only. For clients outside of Oregon, order Rickettsia Antibody Evaluation (87870) . |
|
|
Component |
Reference Range |
|
Rocky Mountain Spotted Fever #1 |
<=1:32 titer |
|
Rocky Mountain Spotted Fever #2 |
<=1:32 titer |
|
Murine Typhus #1 |
<=1:32 titer |
|
Murine Typhus #2 |
<=1:32 titer |
|
Q Fever Phase 1 #1 |
<=1:32 titer |
|
Q Fever Phase 1 #2 |
<=1:32 titer |
|
Q Fever Phase 2 #1 |
<=1:32 titer |
|
Q Fever Phase 2 #2 |
<=1:32 titer |
|
Single titers |
1:32 not significant |
|
|
1:64 borderline; clinical judgment required |
|
|
1:128 evidence of prior infection |
| |
